CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-05 | Paulson Richard A. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-03-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +26,500 | $10.39 | $275K | 36,867 |
| 2020-03-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −7,500 | $23.50 | $176K | 29,367 |
| 2020-03-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −10,000 | $28.00 | $280K | 19,367 |
| 2020-03-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −9,000 | $24.00 | $216K | 10,367 |
| 2020-03-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −26,500 | 76,500 | ||
| 2020-03-02 | Mirza Mansoor Raza Director | Exercise or conversion | +5,000 | $8.06 | $40K | 5,000 |
| 2020-03-02 | Mirza Mansoor Raza Director | Sale | −5,000 | $23.50 | $118K | 0 |
| 2020-03-02 | Mirza Mansoor Raza Director | Exercise or conversion · Stock Option (right to buy) | −5,000 | 0 | ||
| 2020-02-19 | Shah Jatin EVP, Chief Medical Officer | Sale | −1,375 | $16.48 | $23K | 40,759 |
| 2020-02-19 | Frenkel Ran Chief Dev Operations Officer | Sale | −2,975 | $16.48 | $49K | 36,066 |
| 2020-02-19 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −2,961 | $16.48 | $49K | 10,367 |
| 2020-02-19 | Shacham Sharon President & CSO | Sale | −8,817 | $16.48 | $145K | 756,489 |
| 2020-02-19 | Shacham Sharon President & CSO | Sale | −8,817 | $16.48 | $145K | 555,122 |
| 2020-02-19 | Kauffman Michael Chief Executive Officer | Sale | −8,817 | $16.48 | $145K | 555,122 |
| 2020-02-19 | Kauffman Michael Chief Executive Officer | Sale | −8,817 | $16.48 | $145K | 756,489 |
| 2020-02-15 | Shah Jatin EVP, Chief Medical Officer | Exercise or conversion | +4,850 | 42,134 | ||
| 2020-02-15 | Shah Jatin EVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −4,850 | 14,550 | ||
| 2020-02-15 | Frenkel Ran Chief Dev Operations Officer | Exercise or conversion | +9,675 | 39,041 | ||
| 2020-02-15 | Frenkel Ran Chief Dev Operations Officer | Exercise or conversion · Restricted Stock Units | −9,675 | 29,025 |
Page 28 of 29 · 570 trades